Paul Schnell has been named one of the leading lawyers in the U.S. and has been recognized globally and in the U.S. as a leading lawyer in areas such as M&A, private equity, corporate governance, corporate, finance, health care and Latin America.


Mr. Schnell has been recognized as a U.S. legal "legend" for being designated among the top 500 lawyers practicing in the U.S. in each of the last 10 years (Lawdragon). He also has been recognized globally and in the U.S. as a leading lawyer in areas such as M&A (having the highest Band 1 ranking in Chambers), private equity, corporate governance, corporate, finance, health care and Latin America. Surveys that recognize Mr. Schnell include Chambers Global, Chambers USA, U.S. News and World Report, The Best Lawyers in America, Who’s Who Legal, Lawdragon 500 Leading Lawyers in America, IFLR1000 and Chambers Latin America.

In 2015, Mr. Schnell was named as a “Dealmaker of the Year” by The American Lawyer. In 2014, he was the only lawyer twice named “Dealmaker of the Week” by The American Lawyer and the only lawyer to lead two M&A deals ranked by the Financial Times among the year’s most innovative transactions.


In 2015, Mr. Schnell was involved in 39 publicly disclosed transactions, having an aggregate value of $450 billion, including 23 deals valued at more than $1 billion each. He has been active in the United States, Latin America, Europe and Asia, and in all of the BRIC countries.

Mr. Schnell has worked with a large number of the most prestigious companies in the world, advising on major corporate transactions, corporate governance and other matters. In 2015, he counseled companies such as Air Products and Chemicals, Anheuser-Busch, Banco Bradesco, Becton Dickinson, BlackRock, Carlyle Group, Centene Corporation, Humana, JAB Holdings, Pfizer, RIMSA, Rite Aid and Zoetis. He also has advised many of the world’s leading U.S. and international financial firms, including Bank of America, Barclays, BlackRock, BTG Pactual, Carlyle Group, Citigroup, Credit Suisse, Deutsche Bank, Evercore Partners, Goldman Sachs, GP Investimentos, J.P. Morgan, Morgan Stanley and UBS Investment Bank.

Mr. Schnell coordinates the firm’s worldwide health care practice and has an active practice in all sectors of the industry, including pharmaceuticals, services, medical devices and life sciences. Mr. Schnell also chairs the firm’s Latin America practice.


Mr. Schnell has chaired the editorial board of The M&A Lawyer, a leading M&A publication, since its founding in 1997. The editorial board is made up of leading M&A lawyers from around the world. Mr. Schnell also writes and lectures frequently on M&A, corporate governance, private equity and international finance. He chairs the annual M&A Latin Lawyer Conference in Latin America.

Mr. Schnell has been a guest teacher at a number of law schools, including Columbia Law School, Harvard Law School, University of Pennsylvania Law School and Vanderbilt University Law School.

Mr. Schnell serves in leadership positions at numerous educational, arts, social justice and other not-for-profit organizations.

Firm Management

Mr. Schnell has been active in firm management, including serving on Skadden’s governing body, the Policy Committee, and co-chairing the Client Engagement Committee.



  • J.D., New York University School of Law
  • B.A., Amherst College


  • New York

Paul T. Schnell

Partner, Mergers and Acquisitions